Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06610617
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-17
Brief Title:
Neuromodulation of Central Sensory Integration to Improve Postural Control
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Neuromodulation of Central Sensory Integration to Improve Postural Control a Pilot Study in Older Women with Breast Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective is to evaluate if neuromodulation of the PFC can acutely improve sensory integration for balance performance in OTTBCS
Detailed Description:
Sensory integration required for balance will be measured using the sensory organization test which includes six conditions in which visual and proprioceptive sensory cues are sequentially referenced ie reduced to stress available sensory information and sensory integration for postural control Performance on the sensory organization test has been correlated with falls and successful response to balance perturbationBalance performance will be evaluated by postural sway Cognitive function will be assessed using the NIH toolbox with a focus on executive function tDCS will be used to modify PFC excitability and measure its immediate after-effect on balance performance while performing the sensory organization test in OTTBCS CIPN severity will be evaluated using measurements of distal proprioceptionThe study sample will be older breast cancer survivors n20 diagnosed and treated with taxane chemotherapy after the age of 60 years to avoid heterogeneity due to multiple cancer types treatments and sexes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None